Navigation Links
Clinicians in Netherlands Treat Lung Cancer Patients Using New RapidArc Radiotherapy Technology from Varian Medical Systems
Date:10/14/2008

AMSTERDAM, Netherlands, Oct. 14 /PRNewswire-FirstCall/ -- Doctors in the Netherlands have used RapidArc technology from Varian Medical Systems (NYSE: VAR) to treat four early stage lung cancer patients in what is believed to be among the world's first treatments of their kind. Clinicians at VU University Medical Center in Amsterdam now plan to replace conventional stereotactic radiotherapy treatments with RapidArc for all such patients.

A 57-year-old male, diagnosed with a 1.2cm diameter non-small cell lung tumor in the right upper lobe and deemed unfit for surgery as a result of severe emphysema, was the first patient to receive the pioneering radiotherapy treatment at the hospital in early September.

"We normally use ultra-precise stereotactic radiotherapy in these cases and we have now treated more than 400 such patients in this way," said Dr. Ben Slotman, chairman of the hospital's department of radiation oncology. "But RapidArc offers some real time-savings over stereotactic radiotherapy and its use in this case is a real breakthrough for us and our patients."

The pioneering treatment was delivered in less than 15 minutes versus the 30 to 45 minutes normally needed by the team at VU University Medical Center to treat lungs with image-guided intensity-modulated radiotherapy (IMRT). The treatment was delivered using six arcs -- or rotations -- of the treatment machine around the patient. RapidArc delivers a volumetric radiotherapy treatment in a single or multiple arcs of the treatment machine around the patient.

"We were very pleased with how the treatment went," added Dr. Suresh Sunan, professor of clinical experimental radiotherapy. "The online patient setup using cone beam CT scans allowed direct visualization of the tumor just prior to fast treatment delivery using RapidArc, all of which greatly increased the confidence of the treatment team in the precision of delivery. The high dose radiation area was restricted to the tumor and the surrounding healthy tissue and critical organs received very low doses."

"Due to the high precision and the speed of treatment delivery, and the associated increase in patient comfort, RapidArc will eventually replace all 'conventional' stereotactic treatments for early stage lung cancer at our hospital."

RapidArc was introduced by Varian earlier this year and to date more than 30 hospitals around the world are using this new technology for advanced, precise and fast treatments. Non-small cell lung cancer treatments require extremely precise radiotherapy delivery to avoid affecting surrounding critical organs. Worldwide, lung cancer is the leading cause of cancer death in men and the second leading cause of cancer death in women.

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 4,800 people who are located at manufacturing sites in North America and Europe and in its 60 sales and support offices around the world. For more information, visit http://www.varian.com/.


'/>"/>
SOURCE Varian Medical Systems
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
2. Pain medicine meeting unites top researchers and clinicians
3. Does artificial intelligence help clinicians to recognize atrophic gastritis with thyroid disease?
4. Publication Provides a Wake-Up Call For Clinicians Treating Narcolepsy
5. New Evidence Provides Clinicians With Better Tools to Help Smokers Quit
6. CME Publication Gives Clinicians a Leg Up in Treating Disorders of the Lower Extremities
7. Streamline Healths Document Management Solution Integrated into Oacis, Allowing Clinicians to Access Patients Information - Either Scanned or Electronic
8. APCTODAY.com and Convera(R) Launch Vertical Search Site for Advanced Practice Clinicians
9. Report says clinicians should consider economic impact of new interventions
10. AHRQ Releases Two New Resources to Help Consumers and Clinicians Prevent Dangerous Blood Clots
11. New Study Links Animal Agriculture to More Than 20% of MRSA Infections in the Netherlands
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... ... Tuesday, March 28, 2017, is the annual American Diabetes Association Alert Day, ... find out if they are at risk for developing Type 2 diabetes. In recognition ... by programming the LAX pylons the color red. Downtown’s U.S. Bank Tower Crown Lights ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... is pleased to be invited to the Siemens Healthineers annual customer education symposium, ... The event will take place from March 27 - 31, 2017 at the ...
(Date:3/28/2017)... ... 28, 2017 , ... City trips have soared 82% since ... Report). As travelers visit both urban destinations, they are faced with exploration that ... In response, the outdoor industry has blurred the lines between fashion and function ...
(Date:3/28/2017)... ... March 28, 2017 , ... Alert Sentry Group LLC., a leader in the ... Systems), the iSAFE and the iSAFE Plus. These iSAFE products are the most affordable ... the iSAFE and iSAFE Plus offer direct GPS Location and two-way calling with the ...
(Date:3/28/2017)... ... March 28, 2017 , ... The Radiology Business Management ... begun to serve as its new executive director. Mr. Still was selected through a ... , “Bob, as he is known to our members, has been a part ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , March 28, 2017  Market leading ... announced a partnership with premium news content provider ... companies to extract key insights from Dow Jones ... technology. The Linguamatics I2E platform is ... global pharmaceutical companies. The Linguamatics-Dow Jones partnership helps ...
(Date:3/28/2017)... , March 28, 2017  CASI Pharmaceuticals, ... innovative therapeutics addressing cancer and other unmet medical ... American Association for Cancer Research annual meeting.  The ... is entitled "Evaluation of ENMD-2076 in Combination ... the second poster to be presented on April ...
(Date:3/28/2017)... , March 28, 2017 Elysium ... with Cambridge academic ...   The Milner Therapeutics Institute today announces Elysium ... Health has committed significant investment for collaborative projects with academic ... four years. This is the first major research investment outside ...
Breaking Medicine Technology: